Managed Care after Acute Myocardial Infarction (MC-AMI) Reduces Total Mortality in 12-Month Follow-Up-Results from a Poland's National Health Fund Program of Comprehensive Post-MI Care-A Population-Wide Analysis.
cardiac rehabilitation
cardiovascular prevention
mortality
myocardial infarction
post-infarction prognosis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Sep 2020
30 Sep 2020
Historique:
received:
04
08
2020
revised:
07
09
2020
accepted:
28
09
2020
entrez:
3
10
2020
pubmed:
4
10
2020
medline:
4
10
2020
Statut:
epublish
Résumé
Advances in the acute treatment of myocardial infarction (AMI) substantially reduced in-hospital mortality, but the post-discharge prognosis is still unacceptable. The Managed Care in Acute Myocardial Infarction (MC-AMI) is a program of Poland's National Health Fund that aims at comprehensive post-AMI care to improve long-term prognosis. The aim of the study was to assess the effect of MC-AMI on all-cause mortality in one-year follow-up. MC-AMI includes acute MI treatment, complex revascularization, cardiac rehabilitation (CR), scheduled one-year outpatient follow-up, and prevention of sudden cardiac death. In this retrospective observational study performed in a province of Silesia, Poland, we analyzed 3893 MC-AMI participants, and compared them to 6946 patients in the control group. After propensity score matching, we compared two groups of 3551 subjects each. To assess the effect of MC-AMI and other variables on mortality, we preformed a Cox regression. MC-AMI was related with mortality reduction by 38% in a 12-month observation period and the effect persisted even after. Multivariable Cox regression analysis revealed MC-AMI participation to be inversely associated with 1-year mortality (HR 0.52, 95%CI 0.42-0.65, Participation in MC-AMI reduced 1-year mortality by 38% and the effect persisted after the program had been completed.
Identifiants
pubmed: 33008030
pii: jcm9103178
doi: 10.3390/jcm9103178
pmc: PMC7600386
pii:
doi:
Types de publication
Journal Article
Langues
eng
Commentaires et corrections
Type : CommentIn
Références
EuroIntervention. 2015 Oct;11(6):634-42
pubmed: 25308300
Arch Med Sci. 2019 Jun 06;16(3):551-558
pubmed: 32399102
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Cochrane Database Syst Rev. 2016 Jan 05;(1):CD001800
pubmed: 26730878
JAMA. 2015 Jun 23-30;313(24):2433-40
pubmed: 26103027
Circulation. 2012 May 29;125(21):2613-20
pubmed: 22550156
Heart. 2014 Apr;100(7):582-9
pubmed: 24436220
Eur J Prev Cardiol. 2016 Dec;23(18):1914-1939
pubmed: 27777324
Ann Intern Med. 2012 Sep 18;157(6):407-16
pubmed: 22986378
J Clin Med. 2018 Dec 04;7(12):
pubmed: 30518047
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):532-40
pubmed: 22740013
BMJ. 2012 Jan 25;344:e356
pubmed: 22279115
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Int J Cardiol. 2019 Dec 1;296:8-14
pubmed: 31256995
Eur Heart J. 2014 Apr;35(15):979-88
pubmed: 24558113
Rev Esp Cardiol (Engl Ed). 2012 May;65(5):401-2
pubmed: 22425437
Eur J Prev Cardiol. 2016 Apr;23(6):636-48
pubmed: 25687109
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
Circulation. 2017 Jan 3;135(1):38-47
pubmed: 27881561